NephroCare

What NephroCare does

NephroCare is the patient-facing dialysis care brand and clinic network operated by Fresenius Medical Care, delivering in-center haemodialysis, peritoneal dialysis, and haemodiafiltration to patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD). The network spans 800+ dialysis centers across more than 30 countries in Europe, the Middle East, and Africa, performing approximately 10 million treatments per year, and is staffed by over 20,000 employees. NephroCare's India subsidiary, Nephrocare Health Services, operates across 288 cities with 50%+ market share and conducts 3.3 million dialysis sessions annually, making it the largest dialysis provider in India.

The core product is clinical dialysis delivered through two channels: captive (owned-and-operated) clinics and public-private partnership (PPP) contracts with hospitals, where India captive clinics contributed 36.51% of H1 FY26 revenue. Supporting the core service are digital tools such as the myCompanion mobile app (launched 2019, available in 22 countries with 6,500+ active users), Holiday Dialysis coordination that lets patients travel within the network, and NephroCare Academy, an accredited dialysis nursing training program that received 'highly commended' EDTNA/ERCA accreditation in 2022. Treatment modalities offered include Online Hemodiafiltration (HDF), High Volume HDF, and Hemodialysis.

NephroCare operates as a private subsidiary brand of publicly listed Fresenius Medical Care AG (Frankfurt and NYSE: FME), with its legal entity domiciled as Fresenius Medical Care Deutschland GmbH in Bad Homburg, Germany. Revenue is generated primarily on a usage-based, pay-as-you-go basis for treatment sessions, with significant exposure to government health scheme pricing and PPP contracts that subject the business to rate caps. In December 2025, the Indian subsidiary opened its IPO to raise ₹871.05 crore, marking the most significant capital-markets event in the brand's history and supporting continued expansion.

Name

NephroCare

Legal name

Fresenius Medical Care Deutschland GmbH

Website

https://nephrocare.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

NephroCare is the dialysis care brand and clinic network of Fresenius Medical Care, operating 800+ centers across 30+ countries in Europe, the Middle East, and Africa to deliver haemodialysis, peritoneal dialysis, and related kidney care services to patients with chronic and end-stage renal disease.

Ownership category

akta.pro rank

Product category

Dialysis Care Services

NAICS

Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Home Health Care Services (62161)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

akta.pro secondary industries

Outpatient Dialysis & Kidney Care Centers (HLAFABAE), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Home Dialysis Programs (Home HD/PD Training & Support) (HLAKAHAK)

Keywords

• Dialysis care services
• Renal replacement therapy
• Haemodialysis treatment
• Peritoneal dialysis
• Kidney disease management

Headquarters

HQ city

Naples

HQ country

Italy

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Dialysis Treatment Services: Revenue generated from conducting dialysis sessions across captive clinics and hospital partnerships. Conducted over 3.3 million dialysis sessions in FY 2024-25.
2. Public-Private Partnership (PPP) Contracts: Revenue from government health schemes through PPP contracts, though this creates sector pricing pressures from government health schemes.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

NephroCare operates a multinational dialysis clinic network providing in-center haemodialysis, peritoneal dialysis, and haemodiafiltration to patients with end-stage renal disease and chronic kidney disease across 800+ centres in over 30 countries. Its offering also extends to home dialysis support, holiday dialysis coordination across partner clinics, and NephroCare Academy-accredited education for healthcare professionals. The myCompanion mobile app complements the clinical services by enabling haemodialysis patients to manage their treatment journey.

Product overview

NephroCare is a dialysis care network operated by Fresenius Medical Care, offering in-center haemodialysis, peritoneal dialysis, and related kidney care services across Europe, the Middle East, and Africa. The core offering is dialysis treatment at clinics, supplemented by the myCompanion patient mobile app, educational resources, holiday dialysis coordination, and professional training programs through NephroCare Academy. The portfolio operates as a service-based model centered on clinical dialysis care, with digital patient engagement tools as a complementary offering.

Differentiator

Problem solved

Functional benefit

Brands

• myCompanion: Mobile application launched in September 2019 for haemodialysis patients to take a more active role in their treatment. Currently available in 22 countries with over 6,500 active users.

Products and services

• In-Center Haemodialysis In-centre haemodialysis treatment delivered to patients with end-stage renal disease at NephroCare's network of 800+ clinics across more than 30 countries in Europe, the Middle East, and Africa, using Fresenius Medical Care dialysis equipment and supplies.
• Peritoneal Dialysis Home-based peritoneal dialysis service enabling patients to manage their kidney failure treatment outside the clinic, supported by NephroCare's clinical care teams and educational content.
• Haemodiafiltration (Online HDF / High Volume HDF) Advanced dialysis treatment modality (Online Hemodiafiltration and High Volume Hemodiafiltration) offered at NephroCare clinics, providing enhanced blood purification for patients with end-stage renal disease.
• Holiday Dialysis Coordination Service Cross-clinic coordination service that lets dialysis patients arrange haemodialysis sessions at destination NephroCare clinics in other countries, with handling of medical documentation and scheduling to maintain continuity of care while travelling.
• myCompanion App Patient-facing mobile application that helps haemodialysis patients track and manage their treatment journey, access health information, and coordinate with their care teams; available in 22 countries with over 6,500 active users.
• NephroCare Academy Dialysis Nursing Program Accredited clinical education and training program for healthcare professionals covering Fundamental, Advanced, Specialized, and Leadership dialysis training areas; received EDTNA/ERCA 'highly commended' accreditation with 25 Learning Hours recognised for continuing professional development.

Quantifiable outcome

• Operating profit margin improved from 22.35% to 23.43%
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• EDTNA/ERCA (European Dialysis and Transplant Nurses Association/European Renal Care Association)coreStrategic or Co-development Partner · 1 January 2022EDTNA/ERCA provides accreditation for NephroCare Academy's Dialysis Nursing Program, recognizing it as 'highly commended' - the highest accreditation category. The program is recognized with 25 Learning Hours supporting nurses in obtaining continuing professional development evidence required to maintain nursing licenses in some countries.
• Healthcare Facilities (Saudi Arabia)coreStrategic or Co-development PartnerNephroCare operates dialysis centers within healthcare facilities in Saudi Arabia, providing treatments including Online Hemodiafiltration (HDF), High Volume Hemodiafiltration (HV-HDF), and Hemodialysis (HD) at 21 dialysis stations serving approximately 120 patients.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Regional players

• Centers for Dialysis Care: Regional nonprofit dialysis provider in the US Midwest with in-centre, home, and peritoneal dialysis services. Smaller-scale peer with a comparable full-modality care model.

Direct peers

• American Renal Associates: US dialysis chain operating clinics across multiple states before its 2021 take-private. Direct comparator on multi-site in-centre haemodialysis delivery to ESRD patients.
• DaVita Inc. The largest direct competitor to Fresenius Medical Care/NephroCare globally; operates thousands of dialysis centres across the US and a growing international footprint. Both compete on clinic density, treatment outcomes, and integrated patient services.
• B. Braun Avitum: Dialysis services arm of B. Braun, one of the world's largest medical technology companies; operates haemodialysis centres across Europe and other regions. Competes head-on with NephroCare in EMEA and shares the integrated manufacturer-plus-services model.
• U.S. Renal Care: US-based dialysis services provider operating hundreds of in-centre and home dialysis clinics. Comparable clinic-network model and chronic-care patient base, though geographically focused on the US rather than EMEA.
• Diaverum: Global dialysis services provider operating several hundred clinics across Europe, Latin America, the Middle East, and Asia. Closely comparable to NephroCare in EMEA clinic-network model, treatment modalities, and patient-centric services.
• Satellite Healthcare: US nonprofit operator of dialysis centres and home dialysis programs. Comparable in-centre + home dialysis service portfolio and chronic kidney disease patient focus, although smaller in scale and US-only.

Emerging players

• Outset Medical: US-listed medical device company with the Tablo haemodialysis system designed for clinic and home use. Emerging threat to traditional in-centre dialysis providers like NephroCare as the home modality gains traction.

Broad incumbents

• Baxter International: Global medical products company and leader in peritoneal dialysis (PD) solutions and equipment; competes with NephroCare on home PD modality and broader renal care supplies. Relevant as both a modality competitor and adjacent industry incumbent.
• Fresenius Medical Care AG: Parent company of NephroCare and the broader global dialysis incumbent. Operates 3,900+ centres in 50+ countries; directly comparable because NephroCare is the EMEA patient-care brand of this larger, integrated equipment-plus-services enterprise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/FME_Global
• Facebookfacebook.com/freseniusmedicalcare.corporate
• LinkedInlinkedin.com/company/nephrocare-spa

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NephroCare